Jury Orders AbbVie To Pay $150 Million In AndroGel Lawsuit Trial

   

AndroGel Lawsuit Filings Allege Men Suffered Blood Clots, Heart Attacks, And Strokes After Taking Prescription Testosterone Therapy Drugs.

AndroGel Lawsuit Androgel-testosterone-lawsuits-southern-med-lawA federal jury awarded $150 million to an Oregon man who claimed he suffered a heart attack due to taking the AndroGel testosterone drug. This was the first testosterone lawsuit trial against AbbVie and it’s first lost. Thousands of testosterone lawsuits are pending litigation and this was the bellwether trial in this litigation. The plaintiff for this lawsuit contended that AbbVie hid the heart-attack risk associated with AndroGel. The jury did not award the plaintiff compensatory damages but awarded $150 million in punitive damages after finding AbbVie misrepresented AndroGel as a safe product. Punitive damages are meant to punish defendants for their actions.
[bloomberg.com/news/articles/2017-07-24/abbvie-ordered-to-pay-150-million-damages-in-low-t-trial]

“We are pleased with the jury’s verdict in finding that AbbVie to has misrepresenting the safety and risks associated with the testosterone drug,” says Dr. François Blaudeau, surgeon and founder of Southern Med Law.

Southern Med Law’s understanding of medical and legal issues involved in testosterone drug lawsuits empowers the firm’s attorneys to provide the aggressive and effective advocacy for men who believe they have been harmed by prescription testosterone products. If you or a loved one have been injured by testosterone replacement therapy medication, call Southern Med Law today at 205-547-5525 for a free, no-obligation testosterone therapy lawsuit review or by visiting www.southernmedlaw.com and filling out our online form.

The jury returned the verdict Monday after a thee-week trial in the Northern District of Illinois. Over 6,000 low testosterone lawsuits are pending in this multidistrict litigation (MDL). The complaints assert that prescription testosterone products, including AndroGel, Androderm and Axiron, may cause heart attacks, strokes, and blood clots which can lead to death. The “Low-T” lawsuits also claim that testosterone Drug manufacturers failed to adequately warn of the cardiovascular side effects associated with their prescription testosterone products. The majority of the lawsuits in the MDL are filed against AbbVie and Abbot Laboratories, which makes and markets AndroGel. (In re: Testosterone Replacement Therapy Product Liability Litigation – AndroGel Lawsuit MDL No. 2545)

The Oregon man, now 54, said he was prescribed AndroGel in 2007 to treat his low testosterone levels. In November 2012, he had a heart attack at the age of 49. The plaintiff accused AbbVie of misrepresenting AndroGel as a safe treatment for low testosterone levels. Like other AndroGel lawsuits, the plaintiff claims AbbVie knew or should have known about the dangers of AndroGel and should have warned doctors and their patients about the heart attack risks linked to the product. (AndroGel Lawsuit Case No.14-9178, In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Bellwether trials, like the AndroGel trial, are considered test trials that help plaintiffs, defendants and the court gauge how juries will respond to the plaintiffs’ claims. The trials also help the parties determine whether to
settle similar cases pending in litigation. U.S. District Judge Matthew Kennelly, who is managing the MDL in Northern Illinois, plans to hold six AndroGel bellwether trials this year. (AndroGel Lawsuit Case No.14-9178, In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Testosterone replacement therapy products are approved by the U.S. Food and Drug Administration (FDA) to treat hypogonadism, which is abnormally low testosterone levels not related to the male aging process. After reviewing studies that linked serious cardiovascular events with use of prescription testosterone products, the FDA launched an investigation in January 2014 into all FDA-approved testosterone replacement therapies. Two months later, the FDA required testosterone manufacturers to update their product labels and add information on the possible increased risk of heart attacks and strokes in patients taking testosterone products.
[fda.gov/Drugs/DrugSafety/ucm383904.htm]
[fda.gov/Drugs/DrugSafety/ucm436259.htm]

About Southern Med Law And Filing A Testosterone Drug Lawsuit

Throughout his career, Southern Med Law’s Founder, Dr. François Blaudeau, has worked hard to develop a strong reputation in healthcare litigation. Along with attorney Bleadeau, the firms attorneys have a strong knowledge of medical device and harmful drug litigaiton. They are strong advocates for fair legal representation of victims across the country.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
francois@southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam
www.southenmedlaw.com
Like us on Facebook
Follow us on Twitter

This entry was posted in Southern Med Law | Article. Bookmark the permalink.